Resonant Voice Therapy for Phonotraumatic Vocal Lesions
This study aims to evaluate how effective resonant voice therapy is in reducing the severity of vocal fold lesions and improving the voice handicap in individuals with phonotraumatic vocal lesions.
Resonant voice therapy
Basic Science Study
Summary
Study start date: December 1, 2025
Actual date on which the first participant was enrolled.This study focuses on understanding how a voice therapy technique known as resonant voice therapy can help in reducing the pressure on vocal cords, especially in adults who have certain types of vocal cord lesions caused by voice misuse or overuse. These lesions, known as phonotraumatic lesions, can cause discomfort and affect voice quality. The study aims to see if this therapy can make physical changes in the throat and vocal cords that result in less pressure on the vocal cords. This is important because reducing this pressure might lead to better voice quality and less strain, which could improve overall vocal health for people with these lesions. Participants in the study are adults who have been diagnosed with specific types of vocal cord lesions and are referred for resonant voice therapy, which is a standard treatment for such conditions. The therapy involves weekly sessions over four weeks, where participants engage in exercises that help them use their voice in a way that reduces strain. Throughout the study, various measurements are taken, such as pressure on the vocal cords, and participants also complete a questionnaire about how their voice affects their daily life. These assessments are done before therapy begins, immediately after the first session, and after completing all sessions to see how the therapy helps over time. The study also involves using scans and video recordings to observe any physical changes in the throat during speaking, ensuring accurate evaluation of the therapy's impact on vocal health.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Basic Science Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: * Ages 18-40 years (to minimize developmental changes associated with adolescent and elderly age) * Clinic diagnosis by a fellowship trained laryngologist of mid-membranous lesions that by history and appearance are phonotraumatic * Must be referred for voice therapy Exclusion Criteria: * Medical comorbidities (e.g., autoimmune disorders) beyond seasonal allergy and laryngopharyngeal reflux * Vocal fold lesions generally regarded to be less responsive to voice therapy (e.g. vocal fold cysts). * Claustrophobia * Inability to replicate fundamental frequencies required for the study at the intensity levels determined
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location